GCVI Summit 2018
Skip Content

Corporate Venturer

7 October 2014

Bristol-Myers Squibb and Pfizer have a heart

Non-profit organisations including Regents of Michigan University are to receive more than a combined $1m in charitable donations.

Author: Thierry Heles, reporter

Bristol-Myers Squibb and Pfizer have announced the donation of more than $1m to educational initiatives supporting patients suffering from cardiovascular disease. Among the recipients, which will each be given a share of the $1m, are the Regents of Michigan University and the Society for Vascular Medicine, headed by Michigan’s School of Medicine professor James Froehlich.

The other recipients are the US National Stroke Association, Heart Rhythm Society, American College of Physicians, American Heart Association Founders Affiliate, WomenHeart and American College of Emergency Physicians.

The money will be spread out between 2014 and 2016, and will be given with a view of supporting the organisations develop, independently, innovative educational materials about stroke risk reduction in patients with non-valvular atrial fibrillation (NVAF), the most common form of abnormal heart rythm.

Specifically, the organisations will be asked to work on educational materials addressing disease awareness, correct identification of symptoms, access to care and appropriate treatment options. The aim is to publish the materials understandable to both patient and carer.

Christoph Koenen, vice-president at US Medical Cardiovascular at Bristol-Myers Squibb, said: “Bristol-Myers Squibb and Pfizer are committed to helping patients living with NVAF better understand their increased risk for stroke and how to take action to appropriately manage this risk. We are proud to support these organisations in their efforts to help educate and empower patients and caregivers.”

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed